3Karavitaki N, Bmfani C, Warner JT, et al. Craniopharyn- giomas in.children and adults: systematic analysis of 121 cases with long-term follow-up [J]. Clin Endocrinol (Oxf), 2005, 62(4): 397-409.
4Honegger J, Buchfelder M, Fahlbusch R. Surgical treatment ofcraniopharyngiomas: endocrinological results [J]. J Neuro- surg, 1999, 90(2): 251-257.
5Chakrabarti I, Amar AP, Couldwell W, et o1. Long-term neurological, visual, and endocrine outcomes following transnasal resection of craniopharyngioma [J]. J Neurosurg, 2005, 102(4): 650-657.
6Landolt AM, Zachmann M. Results of transsphenoidal extirpation of craniopharyngiomas and Rathke's cysts [J]. Neurosurgery, 1991, 28(3): 410-415.
7Geffner ME. Hypopituitarism in childhood [J]. Cancer Con- trol, 2002, 9(3): 212-222.
8van der Heide-Jalving M, Kamphuis P J, van der Laan MJ, et al. Short- and long-term effects of neonatal glucocorticoid therapy: is hydrocortisone an alternative to dexamethasone [J]? Acta Paediatr, 2003, 92(7): 827-835.
9Li Voon Chong JS, Groves T, Foy P, et al. Elderly people with hypothalamic-pituitary disease and untreated GH deficiency: clinical outcome, body composition, lipid profiles and quality of life after 2 years compared to controls [J]. Clin Endocfinol (Oxf), 2002, 56(2): 175-181.
10Monson JP, Jonsson P. Aspects of growth hoemone (GH) replacement in elderly patients with GH deficiency: data from KIMS [J]. Horm Res, 2003, 60(Suppl 1): 112-120.
